LucidScope
AI is already answering questions about your brand. LucidScope shows you what it’s saying, and why.
LucidScope evaluates how leading AI systems respond to real-world questions about your company, products, indications, and competitors.
It maps visibility and positioning in AI-generated answers, traces the sources shaping those answers, and highlights gaps where evidence is missing, outdated, or misrepresented.
What you can do with LucidScope:
-
Perception Mapping: Compare how AI positions your brand versus key competitors.
- See how AI frames your brand versus competitors, by theme and attribute.
-
Answers Mapping: See how models answer the same stakeholder questions, and where they diverge.
- View side-by-side model answers to your key questions, with differences highlighted.
-
Source Tracing: Identify which websites and documents are shaping AI answers, and where to intervene.
- Understand which domains and documents drive the answers, and what’s missing.
-
Launch and campaign monitoring: Track changes over time across models, markets, and topics.
- Monitor shifts in positioning, key claims, and cited sources (you vs competitors).
LucidScope is part of LucidQuest’s intelligence stack, complementing our primary research, conference coverage, and wargaming capabilities.
Combined with NexusBrain (nexusbrain.io), LucidScope insights can be mapped alongside your team’s own field observations to give a complete picture of how AI is shaping your brand’s perception.
Want to see what AI is saying about your brand? Request an AI Answer Audit.
You’ll receive a short report covering Perception, Answers, Source Tracing, and Zero-click gaps.
Already evaluating tools? Test LucidScope.
Questions or feedback? Email us anytime.
December 9, 2025
Endocrinology Today—December 9, 2025
December 9, 2025
Lucid Diligence Brief: Mirum to acquire Bluejay Therapeutics
December 8, 2025
Hematology Today—December 8, 2025
December 8, 2025
Oncology Today—December 8, 2025
December 8, 2025
Oncology Video Recap—December 8, 2025
December 8, 2025
Lucid Diligence Brief: SciNeuro Pharmaceuticals $53M financing
December 5, 2025
SABCS 2025 Preview: Key Breast Cancer Highlights to Watch
December 5, 2025
Vaccines Today—December 5, 2025
December 5, 2025
Respiratory Today—December 5, 2025
December 5, 2025